Instructions for Authors

JE accepts the following article types.

• Original Research: a full report of new findings, with complete methods and results.
• Review: a critical, structured synthesis of the literature on a developmental topic.
• Systematic Review and Meta-Analysis: a review that follows a stated protocol and reporting guideline.
• Methods: a new or substantially improved method, model, protocol or resource, with evidence that it works.
• Short Communication: a concise report of a focused finding.
• Case Report: a clinically or biologically informative case, reported with consent.
• Commentary: an argued perspective on a recent development in the field.
• Letter: a brief response to an article published in JE.

The editorial office can advise whether a planned manuscript suits the journal before submission; use the editorial email route described under Submitting below.

Manuscripts are written in clear English and are submitted as an editable Word or equivalent file. Original Research follows this order:

1. Title page: title, authors, affiliations, corresponding author, ORCID iDs where available
2. Abstract, with a short list of keywords
3. Introduction
4. Materials and Methods
5. Results
6. Discussion
7. Declarations: ethics, consent, data availability, funding, competing interests, author contributions, acknowledgments
8. References

Reviews, Systematic Reviews, Methods papers, Short Communications, Case Reports, Commentaries and Letters adapt this order to their content. Systematic reviews report their protocol and registration, if any.

All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.

For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.

Report the approvals, consent and permits that apply to the work: ethics committee approval and informed consent for human participants; the approval and donor consent that apply to human embryos, gametes and embryo models, with the national regulation followed; animal-care approval and field permits. The Editorial Policies set out these requirements.

Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.

Authors follow the reporting guideline that fits the study design and submit the completed checklist where one exists.

Every empirical research manuscript must include a data-availability statement. Deposit of data in a recognized repository, and of code in an archived repository with a version, is encouraged. Sequence, expression and structural data are deposited in the relevant public database and the accession numbers are given in the manuscript. See Data Archiving and Permissions.

Figures are supplied as separate high-resolution files in a common format such as TIFF, PNG or JPEG, with a numbered legend that explains every panel, symbol and scale bar. Microscopy and other images state the specimen, stage, magnification and any processing. Adjustments are applied to the whole image and do not obscure or add information.

Tables are editable text in the manuscript, numbered, with a title and notes that define abbreviations.

Describe the sample size and how it was determined, the unit of replication, the tests used and how data were excluded, if at all. Report effect sizes and uncertainty, not only p values, and state how many independent experiments, embryos or animals each result represents.

Cite published and accepted work, datasets and preprints in the text, and list every cited source in the reference list. Examples of the expected form:

Journal article: Author A, Author B. Title of the article. Journal Name. 2024;12(3):45–58. doi:10.xxxx/xxxxx

Book: Author A. Title of the Book. 3rd ed. Publisher; 2022.

Web page: Organization. Title of the page. Accessed Month Day, Year. URL

Dataset: Author A. Title of the dataset. Repository; 2024. doi:10.xxxx/xxxxx

Preprint: Author A. Title of the preprint. Preprint server. Posted Month Day, Year. doi:10.xxxx/xxxxx

Trial registration: Registry name. Identifier. Title of the trial. Registered Month Day, Year. URL

Supplementary files are cited in the text, supplied in open formats, and described in a legend. Authors obtain written permission before submission for any third-party material, including figures reproduced from other publications, unless the license under which it was published already allows the reuse (as CC BY does); in every case the source is credited in the caption. See Data Archiving and Permissions.

Generative AI tools cannot be listed as authors. Authors disclose any use of such tools in preparing the text, images or analysis, name the tool, and remain responsible for the content. AI-generated or altered images are not accepted in place of data.

Submit through one of the three routes below.

1. ManuscriptZone Primary route

   The journal’s manuscript-handling system, where submission, review and decisions are managed.

   Submit through ManuscriptZone

2. Simple manuscript submission form Alternative route

   A single online form with the Journal of Embryology already selected.

   Open the JE submission form

3. Editorial email Assisted route

   For authors who cannot use either online route, write to the editorial office.

   info@openaccesspub.org

Authors must use only one submission route for the same manuscript.

The article processing charge is USD 1,200, payable only after acceptance; withdrawal after submission is subject to the journal’s withdrawal policy.

• The article type and scope fit the journal.
• Authors, affiliations, funding and competing interests are complete.
• Ethics approvals, consent, permits and trial registration are reported where they apply.
• A data-availability statement is included for empirical research.
• Figures, tables and legends are complete, and permission is attached for any reused material whose existing license does not already allow the reuse.
• The reporting checklist is attached where one applies.
• Use of AI tools is disclosed.
• For double-blind review, identifying information is in the title-page file or submission form only.